Abstract
For a ketogenic diet to be effective, strict control of carbohydrate intake is paramount. Factors such as medications may upset this delicate balance. The aim of this commentary is to provide physicians who are treating patients with a ketogenic diet, with a step-by-step guide. A list of unsuitable excipients was established. A flowchart with the title “Can this drug be prescribed to a patient following a ketogenic diet?” was then drafted. The first step is to determine the international nonproprietary name, dosage, form and composition. The amount of unsuitable excipients is calculated. Suitable alternatives may be discussed with the pharmacist. As a last resort, the ketogenic diet itself may need to be adapted. The answers provided are included in a database. Determining the amount of unsuitable excipients is a complex task requiring pharmaceutical expertise. Our flowchart can be used in order to provide a clear pathway for answering such questions.
Similar content being viewed by others
References
Wilder RM. The effect of ketonemia on the course of epilepsy. Mayo Clin Proc. 1921;2:307–8.
Sharma S, Jain P. The ketogenic diet and other dietary treatments for refractory epilepsy in children. Ann Indian Acad Neurol. 2014;17(3):253–8.
Neal EG, Chaffe H, Schwartz RH, Lawson MS, Edwards N, Fitzsimmons G, et al. The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. Lancet Neurol. 2008;7(6):500–6.
Freeman JM, Vining EPG, Kossoff EH, Pyzik PL, Ye X, Goodman SN. A blinded, crossover study of the efficacy of the ketogenic diet. Epilepsia. 2009;50(2):322–5.
Lambrechts DAJE, de Kinderen RJA, Vles JSH, de Louw AJA, Aldenkamp AP, Majoie HJM. A randomized controlled trial of the ketogenic diet in refractory childhood epilepsy. Acta Neurol Scand. 2017;135(2):231–9.
Bailey EE, Pfeifer HH, Thiele EA. The use of diet in the treatment of epilepsy. Epilepsy Behav. 2005;6(1):4–8.
Kossoff EH, Zupec-Kania BA, Auvin S, Ballaban-Gil KR, Christina Bergqvist AG, Blackford R, et al. Optimal clinical management of children receiving dietary therapies for epilepsy: updated recommendations of the International Ketogenic Diet Study Group. Epilepsia Open. 2018;3(2):175–92.
Rowe R, Sheskey P, Quinn M. Handbook of pharmaceutical excipients. 6th ed. London: Pharmaceutical Press; 2009. ISBN 978-1582121376.
Lebel D, Morin C, Laberge M, Achim N, Carmant L. The carbohydrate and caloric content of concomitant medications for children with epilepsy on the ketogenic diet. Can J Neurol Sci. 2001;28(4):322–40.
Feldstein TJ. Carbohydrate and alcohol content of 200 oral liquid medications for use in patients receiving ketogenic diets. Pediatrics. 1996;97(4):506–11.
Fitzsimmons G, Eltze C. Ketogenic diet. https://www.gosh.nhs.uk/health-professionals/clinical-guidelines/ketogenic-diet. Cited 15 Jul 2019.
Charlie Foundation. No and low carb personal care products. https://charliefoundation.org/wp-content/uploads/2017/12/LowNoCarb-download.pdf (2014). Cited 15 Jul 2019.
Curless J. Medication management on the ketogenic diet. https://www.choc.org/wp/wp-content/uploads/2017/03/RT-6-CurlessJ-RDsInPractice-Keto.pdf. Cited 15 Jul 2019.
Hagopian K, Ramsey JJ, Weindruch R. Enzymes of glycerol and glyceraldehyde metabolism in mouse liver: effects of caloric restriction and age on activities. Biosci Rep. 2008;28(2):107–15.
Le Dare B, Aubin F, Barbazan C, Rucheton A, Boivin P-N, Delaunay S, et al. Régime cétogène et médicaments en pédiatrie à l’hôpital. Pharm Hosp Clin. 2016;51(1):72.
McArtney R, Bailey A, Champion H. What is a ketogenic diet and how does it affect the use of medicines? Arch Dis Child Educ Pract Ed. 2017;102(4):194–9.
Zidan A, Alshiekh-Nasany R, Bragin I. Carbohydrate-content of amoxicillin breaks ketogenesis causing breakthrough seizures. In: Annals of neurology. Conference: 139th annual meeting of the American Neurological Association, ANA 2014 Baltimore, MD, USA. Conference start: 20141012 conference end: 20141014. Conference publication, vol. 76; 2014, p. S33.
Jung DE, Joshi SM, Berg AT. How do you keto? Survey of North American pediatric ketogenic diet centers. J Child Neurol. 2015;30(7):868–73.
Walczyk T, Wick JY. The ketogenic diet: making a comeback. Consult Pharm. 2017;32(7):388–96.
Misiewicz Runyon A, So T-Y. The use of ketogenic diet in pediatric patients with epilepsy. ISRN Pediatr. 2012;2012:263139.
Acknowledgements
We would like to thank the members of the multidisciplinary team in Nancy University Regional Teaching Hospital, including the pediatricians, dieticians and pharmacists, who are all involved in the management of patients on a ketogenic diet. Thanks to Dr. Helen Mecili for her English language corrections.
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
None.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Nisse, YE., Robert, S., Menetre, S. et al. Ketogenic diet: a pharmaceutical guide for the management of drug therapy in the pediatric population. Int J Clin Pharm 42, 326–330 (2020). https://doi.org/10.1007/s11096-020-01013-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11096-020-01013-4